ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU
zacks.com
Want to monitor VLTAF?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor VLTAFNo data available
No company information available